title: [Asthma therapy in transition. "For the physician it becomes ever more complicated" (interview by Dr. Elke Oberhofer)].
authors.forename: Adrian
authors.initials: A
authors.lastname: Gillissen
authors.forename: Elke
authors.initials: E
authors.lastname: Oberhofer
mesh_terms: D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000888:Antibodies, Anti-Idiotypic / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D001249:Asthma / Q000175:diagnosis / Q000188:drug therapy* / Q000276:immunology; D001592:Benzyl Alcohols / Q000627:therapeutic use; D001688:Biological Products / Q000627:therapeutic use*; D002722:Chlorobenzenes / Q000627:therapeutic use; D016207:Cytokines / Q000097:blood; D017277:Drug Approval; D005858:Germany; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood; D056687:Off-Label Use; D000069444:Omalizumab; D010819:Physician's Role; D012221:Rhinitis, Allergic, Perennial / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology; D012602:Scopolamine Derivatives / Q000627:therapeutic use; D000069447:Tiotropium Bromide
chemical_list: D018927:Anti-Asthmatic Agents; D000888:Antibodies, Anti-Idiotypic; D061067:Antibodies, Monoclonal, Humanized; D001592:Benzyl Alcohols; D001688:Biological Products; D002722:Chlorobenzenes; D016207:Cytokines; D012602:Scopolamine Derivatives; C550468:vilanterol; D000069444:Omalizumab; D007073:Immunoglobulin E; D000069447:Tiotropium Bromide